Contract Extension, Earnings Release, Process Up gradation, Market Activity, and New Products - Research Reports on Honeywell, John Deere, Lockheed Martin, Danaher and DR Horton

NEW YORK, August 13, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Honeywell International Inc. (NYSE: HON), Deere & Company (NYSE: DE), Lockheed Martin Corporation (NYSE: LMT), Danaher Corp. (NYSE: DHR) and DR Horton Inc. (NYSE: DHI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5690-100free.

--
Honeywell International Inc. Research Reports
On July 31, 2014, Honeywell International Inc. (Honeywell) reported that a part of its Performance Materials and Technologies strategic business group, Honeywell Process Solutions will upgrade process control and alarm management systems at the Molikpaq platform on the Sakhalin shelf, Russia, to improve safety, reliability and operational efficiency. The Company informed that Molikpaq platform, owned by Sakhalin Energy Investment Co. Ltd., celebrated its 15th anniversary in September 2013. The platform produces 48,000 barrels of crude oil per day. In a separate release, dated July 25, 2014, Honeywell's Board of Directors declared a regular quarterly dividend of $0.45 per share on the Company's outstanding common stock, payable on September 10, 2014 to shareowners of record at the close of business on August 21, 2014. The full research reports on Honeywell are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/HON/report.pdf

--
Deere & Company Research Reports
On August 5, 2014, Deere & Company (John Deere) reported that it has launched two new special edition Gator™ utility vehicles. The limited edition Midnight Black XUV825i and Midnight Black RSX850i are available at select dealers in custom matte black paint scheme with charcoal gray graphics. Commenting on the launch, David Gigandet, John Deere Marketing Manager, Gator utility vehicles, said, "These new models provide customers the durability and productivity they've come to expect with Gators, but in a unique and stylish theme that will capture the attention of John Deere fans and the utility vehicle market." The full research reports on John Deere are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/DE/report.pdf

--
Lockheed Martin Corporation Research Reports
On August 5, 2014, Lockheed Martin Corporation (Lockheed Martin) reported that it will provide facilities development and operations support of human spaceflight missions at NASA's Johnson Space Center in Houston through at least September 30, 2016, under a contract extension. According to Lockheed Martin, the three-year contract extension includes a two-year base period with a one-year option, and is valued at nearly $340 million. Rick Hieb, Vice President, Exploration & Mission Support, Lockheed Martin's Information Systems & Global Solutions business, said, "At the heart of what makes Lockheed Martin unique is the commitment to taking on the hardest challenges and finding ways to solve them, and our longstanding support of NASA's human spaceflight missions demonstrates that commitment." The full research reports on Lockheed Martin are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/LMT/report.pdf

--
Danaher Corp. Research Reports
On July 17, 2014, Danaher Corp. (Danaher) reported its Q2 FY 2014 earnings (period ended June 27, 2014). Net earnings for the quarter were $676.4 million, or $0.95 per diluted share, versus $616.8 million, or $0.87 per diluted share in Q2 FY 2013. According to Danaher, the Q2 2014 net diluted earnings per share included after-tax gain on the sale of marketable securities of $0.02 per share. Revenues for quarter were $5.0 billion, 4.8% higher on YoY basis. Looking forward, the medical equipment & device manufacturer said that it expects GAAP diluted EPS for Q3 FY 2014 to be in the range of $0.86 to $0.89. For FY 2014, Danaher narrowed its diluted EPS guidance to $3.67 to $3.72 on a GAAP basis from $3.60 to $3.75, forecasted earlier. The full research reports on Danaher are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/DHR/report.pdf

--
DR Horton Inc. Research Reports
On August 8, 2014, shares of DR Horton Inc. rose 2.54% from its previous day's close to end the trading session at $20.62. The stock opened at day's low of $20.18 and touched an intraday high of $20.71. A total of 8.06 million shares were traded, higher than the 30-day average trading volume of 6.95 million shares. The stock has a 52-week low of $17.52 and a 52-week high of $25.23. Over the past 12-months, the stock has gained an upside of 9.16%, slightly underperforming the NYSE Composite, which returned 11.11% during the same time period. The full research reports on DR Horton are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/DHI/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review